Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Fig. 2

Rate of therapeutic response to combination therapy evaluated by improvement of FEV1 or CAT score. Sixty-two percent of patients showed an increase in FEV1 greater than 100 mL and the same proportion had a decrease in CAT score of greater than 2 points. When the results of FEV1 and CAT score were combined, the overall response rate of the combination therapy was 82 %

Back to article page